Downregulation of TSC1 and TSC2 via activation of AKT and PI3K by collagen-bound integrin indirectly activates mTOR kinase activity through the GTP binding protein Ras homolog enriched in the brain (Rheb), creating a promising cancer therapeutic target [119,120,121]. Here, AKT1 is linked to cancer.